The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »

Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »

Iroko Pharmaceuticals LLC, a company focused on advancing the science of analgesia, recently received a patent for VIVLODEX (meloxicam) capsules 5 mg and 10 mg. Read More »

Teva Pharmaceuticals Industries Ltd. (Teva) recently announced a settlement with the United States government related to allegations of violating the Foreign Corrupt Practices Act (FCPA) in Ukraine, Mexico and Russia. Read More »

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, recently partnered with Lonza for the manufacture of voclosporin active pharmaceutical ingredient (API). Read More »

Argentina's regulatory body has approved Hemispherx Biopharma's New Drug Application for the commercial sale of rintatolimod. Read More »

Mylan N.V. and Biocon Ltd. released results of their Heritage Study in the Journal of the American Medical Association, showing positive indications for MYL-1401O, the proposed biosimilar trastuzumab co-developed by Mylan and Biocon. Read More »

Endo International has appointed Patrick Barry as U.S. Branded Pharmaceuticals’ new senior vice president and Matthew Davis as the new senior vice president of research and development at Branded. Read More »

Integrated Delivery Networks are continuing to form with the continued growth and mergers of health systems. Read More »

Endo International subsidiary Par Pharmaceutical has begun the shipping process for ezetimibe 10 mg tablets, which is the generic form of ZETIA, developed by Merck. Read More »

Cognition Therapeutics has initiated testing of CT1812 in clinical trials in the United States. Read More »

Endo International plc subsidiary Par Pharmaceutical has released mycophenolate mofetil hydrochloride as an injection in the United States after the Food and Drug Administration gave its approval of Endo’s Abbreviated New Drug Application. Read More »

Endo International and BioDelivery Sciences International (BDSI) have agreed to return the BELBUCA buccal film product to BDSI. Read More »

Rite Aid's Black Friday deals continue through the weekend. Read More »

CSL Behring's Phase 2b clinical trial involving AEGIS-I has turned in positive results. Read More »

Janssen-Cilag International NV's STELARA has been approved by the European Commission to treat adult patients who have moderate-to-severe Crohn’s disease and did not respond well to or are immune to conventional therapy or a tumor necrosis factor alpha antagonist. Read More »

Janssen Pharmaceuticals Inc.'s results of its XARELTO Phase 3b PIONEER AF-PCI clinical trial and new research involving INVOKANA will be featured in presentations at the American Heart Association Scientific Sessions, being held through Wednesday in New Orleans. Read More »

Genentech's 0.5 mg prefilled syringe Lucentis has been approved by the U.S. Food and Drug Administration as a new means to administer the medication. Read More »

PANTHERx Specialty Pharmacy has been recognized as the fifth-best place to work in health care in Modern Healthcare’s ninth annual Best Places to Work in Healthcare Awards, a nationwide program that recognizes the industry’s exceptional organizations. Read More »

Vernalis Therapeutics Inc. has initiated its promotion of MOXATAG Tablets to primary care physicians in the United States. Read More »